Application

17715875 · ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN CANCER TREATMENT

Filed 2022-04-07 · Abandoned The official file ↗ · Art unit 1646 · Examiner Hong Sang Typical · CPC C07K 16/2818 · Seattle Genetics, Inc. · Sterne, Kessler, Goldstein & Fox P.L.L.C.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

24.0 mo

to disposition 42.5 mo

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in